AMICUS THERAPEUTICS, INC. — Board/Management Information 2015

Feb 27, 2015

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*WASHINGTON, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT PURSUANT TO*

*SECTION 13 OR 15(D) OF THE*

*SECURITIES EXCHANGE ACT OF 1934*

Date of Report (Date of earliest event reported): February 25, 2015

*AMICUS THERAPEUTICS, INC.*

(Exact Name of Registrant as Specified in Its Charter)

*Delaware*

(State or Other Jurisdiction of Incorporation)

001-33497	71-0869350
(Commission File Number)	(IRS Employer Identification No.)

1 Cedar Brook Drive, Cranbury, NJ	08512
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (609) 662-2000

(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901922\15-5618-1\task7242160\5618-1-ba.htm',USER='C901922',CD='Feb 28 01:56 2015'

*Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.*

On February 25, 2015, M. James Barrett informed Amicus Therapeutics, Inc. that he has chosen to resign from the Board of Directors effective March 1, 2015.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901922\15-5618-1\task7242160\5618-1-ba.htm',USER='C901922',CD='Feb 28 01:56 2015'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ William D. Baird III
William D. Baird III
Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901922\15-5618-1\task7242160\5618-1-ba.htm',USER='C901922',CD='Feb 28 01:56 2015'